RE: Report, page-11

I have been reading through past announcements as part of my due diligence, I think management has communicated effectively. Keeping the market updated with the various trials thay have signed on. They also have a clear path forward and appear to be executing. Supply contracts for new companies take time, especially when the tech is new also. The only thing that seems to be underperforming (IMO) is the share price, which I would put down to Perennial selling millions in such an illiquid stock. Once that finishes I expect a recovery, I am lucky as I have not been a long term holder and don't have (paper) losses to make back. I believe the first material manufacturing contract will be a proof of concept which will provide for a re-rate, hopefully followed by growing sales and an appreciating share price on underlying financial (tangible) performance.

All IMO, please DYOR and GLTAH